Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (6)
2022
-
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Lung Cancer, Vol. 173, pp. 83-93
-
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
BMC Cancer, Vol. 22, Núm. 1
-
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 6, pp. 1107-1116
2021
1997
-
A metastatic muscle mass as the first manifestation of renal-cell cancer. A case report and review of the literature
Anales de medicina interna (Madrid, Spain : 1984), Vol. 14, Núm. 4, pp. 184-186
-
Quimioterapia del cancer de ovario en estadios I y II de la FIGO
Revisiones en Cancer, Vol. 10, Núm. 5, pp. 222-228